Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles G Drake

Showing results (81-90 of 266) with videos related to

Pageof 27
Sort By:
The Prostate|August 12, 2009
Human prostate-infiltrating CD8+ T lymphocytes are oligoclonal and PD-1+Karen S Sfanos, Tullia C Bruno, Alan K Meeker, et al.
Oncoimmunology|January 18, 2021
Robust antigen-specific CD8 T cell tolerance to a model prostate cancer neoantigenZoila A Lopez-Bujanda, Matthew G Chaimowitz, Todd D Armstrong, et al.
The Prostate|October 23, 2018
A role for paracrine interleukin-6 signaling in the tumor microenvironment in prostate tumor growthShu-Han Yu, Janielle P Maynard, Ajay M Vaghasia, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 2, 2009
Cyclophosphamide unmasks an antimetastatic effect of local tumor cryoablationMoshe Yair Levy, Abhinav Sidana, Wasim H Chowdhury, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly Induced in anergic CD4+ T cellsMichelle A Hurchla, John R Sedy, Maya Gavrieli, et al.
Oncoimmunology|May 3, 2014
Sustained CD4<sup>+</sup> T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomideSusannah Ellsworth, Ani Balmanoukian, Ferdynand Kos, et al.
Cancer Immunology Research|February 27, 2021
Longitudinal Immune Profiling Reveals Unique Myeloid and T-cell Phenotypes Associated with Spontaneous Immunoediting in a Prostate Tumor ModelCasey R Ager, Aleksandar Z Obradovic, Juan M Arriaga, et al.
Cancer Immunology, Immunotherapy : CII|July 22, 2018
Absence of host NF-κB p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarizationTheresa Barberi, Allison Martin, Rahul Suresh, et al.
Plos One|November 6, 2014
Lymphocyte Activation Gene 3 (LAG-3) modulates the ability of CD4 T-cells to be suppressed in vivoNicholas M Durham, Christopher J Nirschl, Christopher M Jackson, et al.
Lancet (London, England)|June 16, 2015
Prostate cancerGerhardt Attard, Chris Parker, Ros A Eeles, et al.
Pageof 27

Showing results (81-90 of 266) with videos related to

Sort By:
Pageof 27
The Prostate|August 12, 2009
Human prostate-infiltrating CD8+ T lymphocytes are oligoclonal and PD-1+Karen S Sfanos, Tullia C Bruno, Alan K Meeker, et al.
Oncoimmunology|January 18, 2021
Robust antigen-specific CD8 T cell tolerance to a model prostate cancer neoantigenZoila A Lopez-Bujanda, Matthew G Chaimowitz, Todd D Armstrong, et al.
The Prostate|October 23, 2018
A role for paracrine interleukin-6 signaling in the tumor microenvironment in prostate tumor growthShu-Han Yu, Janielle P Maynard, Ajay M Vaghasia, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 2, 2009
Cyclophosphamide unmasks an antimetastatic effect of local tumor cryoablationMoshe Yair Levy, Abhinav Sidana, Wasim H Chowdhury, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly Induced in anergic CD4+ T cellsMichelle A Hurchla, John R Sedy, Maya Gavrieli, et al.
Oncoimmunology|May 3, 2014
Sustained CD4<sup>+</sup> T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomideSusannah Ellsworth, Ani Balmanoukian, Ferdynand Kos, et al.
Cancer Immunology Research|February 27, 2021
Longitudinal Immune Profiling Reveals Unique Myeloid and T-cell Phenotypes Associated with Spontaneous Immunoediting in a Prostate Tumor ModelCasey R Ager, Aleksandar Z Obradovic, Juan M Arriaga, et al.
Cancer Immunology, Immunotherapy : CII|July 22, 2018
Absence of host NF-κB p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarizationTheresa Barberi, Allison Martin, Rahul Suresh, et al.
Plos One|November 6, 2014
Lymphocyte Activation Gene 3 (LAG-3) modulates the ability of CD4 T-cells to be suppressed in vivoNicholas M Durham, Christopher J Nirschl, Christopher M Jackson, et al.
Lancet (London, England)|June 16, 2015
Prostate cancerGerhardt Attard, Chris Parker, Ros A Eeles, et al.
Pageof 27